Targan INC
TARGAN is an innovative Animal AgTech company based in Raleigh, North Carolina, focused on sustainable animal health and protein production. Founded in 2015, it develops cutting-edge technology solutions such as WingScan, an AI-driven automated feather sexing system that improves poultry production efficiency, animal welfare, and profitability. TARGAN is expanding its product portfolio with a Vaccine Delivery System that delivers precise individualized ocular vaccines to enhance flock health. The company serves poultry, livestock, and aquaculture industries globally, with growing international adoption and strategic partnerships, positioning itself as a leader in sustainable animal agriculture technology.
Targan INC
TARGAN is an innovative Animal AgTech company based in Raleigh, North Carolina, focused on sustainable animal health and protein production. Founded in 2015, it develops cutting-edge technology solutions such as WingScan, an AI-driven automated feather sexing system that improves poultry production efficiency, animal welfare, and profitability. TARGAN is expanding its product portfolio with a Vaccine Delivery System that delivers precise individualized ocular vaccines to enhance flock health. The company serves poultry, livestock, and aquaculture industries globally, with growing international adoption and strategic partnerships, positioning itself as a leader in sustainable animal agriculture technology.
TL;DR
Founded: 2015
Headquarters: Raleigh, North Carolina
Core product: WingScan (automated feather sexing and vaccine-delivery system)
Latest disclosed round: Series C, May 25, 2022
Notable investors: Mountain Group Partners, NovaQuest Capital Management, Merck Animal Health, Oval Park Capital
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |
Company Overview
Problem Domain
Poultry, livestock, and aquaculture production efficiency and animal health
Founded
2015
Industry
Biotechnology
Funding Track Record
$35,000,000
Existing investors Merck Animal Health and Oval Park Capital participated
Investor Signal
“Has strategic participation from corporate animal-health investor Merck Animal Health and institutional life-science investors”